Announcements Trials

Browse Landscape

Phase

Phase 3 5 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 3 Neoplasms 2 Venous Thrombosis 1 Upper Extremity Deep Vein Thrombosis 1 Thrombosis 1 Multiple Myeloma 1 Head and Neck Neoplasms 1 Fibrosis 1 Catheter-Related Infections 1 Carcinoma, Hepatocellular 1

Interventions

Dalteparin 2 edoxaban 1 apixaban 1 Tinzaparin 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Fluorodeoxyglucose F18 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Venous Thrombosis × apixaban × Clear all

NCT02581176 2018-06-26

CAP

University Hospital, Akershus

Phase 4 Completed

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡